We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for momelotinib (GlaxoSmithKline Australia Pty Ltd)
Active ingredients
momelotinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film coated tablet
Indication
For the treatment of myelofibrosis
Therapeutic area
Oncology